IDO1 and cancer: By evaluating inhibitory efficacy of 25 candidate compounds (0–500 nM) in cancer cell lines (SGC-7901 and MKN45 cells), dexamethasone and TWS-119 revealed obvious inhibitory effect on PD-L1 and IDO1 in a dose-dependent manner (Fig. 1D, Supplementary Fig. S1B).